Gubra A/S (GUBRA.CO) stock: key figures, P/E, revenue and dividend
Health Care · Denmark · ISIN DK0062266474
Gubra A/S financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 265.00 m DKK | 2.64 bn DKK |
| Gross profit | 164.00 m DKK | 2.55 bn DKK |
| Operating income | -50.01 m DKK | 2.15 bn DKK |
| EBIT | -50.00 m DKK | 2.22 bn DKK |
| Net income | -36.00 m DKK | 1.69 bn DKK |
| Diluted EPS – continuing operations | -2.24 DKK | 103.51 DKK |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Gubra A/S
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry; and various services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, bioinformatics, and 2D and 3D histology with artificial intelligence pathology. It also has a portfolio strategy of potential drug candidates in the form of upfront payments, research payments, milestone payments, and royalties; and investments targeting as sets promoting the green transition. The company has partnership and collaboration with Boehringer Ingelheim for the treatment of obesity; Camurus' FluidCrystal technology to develop a therapy for hypoparathyroidism; Amylyx Pharmaceuticals to develop a GLP-1 receptor antagonist for post-bariatric hypoglycemia and other rare diseases. Gubra A/S was incorporated in 2008 and is headquartered in Horsholm, Denmark.
More stocks
- SWS Hemodialysis Care Co. Ltd. A (688410.SS)
- One United Properties SA (ONE.RO)
- Zhejiang Shuangyuan Technology Co. Ltd. A (688623.SS)
- New Trend International Logis-Tech Co Ltd (300532.SZ)
- Winall Hi tech Seed (300087.SZ)
- AO World plc (AO.L)
- IPH Ltd (IPH.AX)
- Plato Income Maximiser Ltd (PL8.AX)
- Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096.SZ)
- Jinxi Axle Co Ltd (600495.SS)
- Beijing UniStrong Science & Technology Co Ltd (002383.SZ)
- Taboola.com Ltd. (TBLA)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.